Latest Board Renewal News

Flight Centre Travel Group reported a profit shortfall in FY25 but remains optimistic for FY26, driven by strategic investments, AI integration, and a diversified global portfolio.

Australian Critical Minerals has appointed geologist Allister Caird as a Non-Executive Director, alongside key leadership shifts including Dean DeLargie's move to Executive Chairman. These changes underscore the company’s strategic push in critical minerals exploration across Australia and Peru.

Austral Resources Australia Ltd has successfully completed a $40 million capital raise and is reinstated to ASX trading, positioning itself as a mid-tier copper producer with a dual-hub operation in Queensland.

McPherson’s Limited updates shareholders on its ongoing transformation journey, reporting modest core brand growth in FY25 and outlining a strategic outlook for FY26 focused on sustainable expansion and operational efficiency.

Pathkey.AI reports strong validation of its TrialKey AI platform’s predictive accuracy and announces key leadership changes as it advances toward commercial scale.

Challenger Limited reported a robust 9% rise in normalised net profit after tax to $456 million for FY25, alongside an 11% dividend increase, while welcoming APRA's capital reforms that promise to boost its financial resilience and growth in retirement income products.

Mineral Resources Limited reported a record quarter with Onslow Iron reaching full capacity and lithium prices surging 31%, while maintaining FY26 guidance and strengthening its Board.

IGO Limited reports improved safety metrics and steady production despite operational headwinds, maintaining a strong balance sheet and positive cash flow.

Data # 3 Limited showcased strong FY25 financial results with record $3 billion gross sales and announced key board changes at its 2025 AGM. The company projects steady growth for FY26 despite some short-term challenges.

Big River Industries faced a tough FY2025 with subdued residential demand but showed resilience through cost control and cash generation. The company declared a modest dividend and announced key board changes as it eyes recovery.

EMU NL has appointed John Anderson as Chair and Adrian Griffin as Managing Director and CEO, marking a significant step in its board renewal process aligned with ASX governance standards.

Anatara Lifesciences reports steady progress in its anti-obesity pre-clinical studies with results expected by year-end, while preparing its GaRP gastrointestinal health data for publication amid ongoing commercial talks. The company also announces a key board appointment and a $1.2 million capital raise.